Respiratory syncytial virus NS1 protein degrades STAT2 by using the elongin-cullin E3 ligase

Joanne Elliott, Oonagh Lynch, Yvonne Suessmuth, Ping Qian, Caroline Boyd, James Burrows, Lizzie Buick, Nigel Stevenson, Olivier Touzelet, Massimo Gadina, Ultan Power, James Johnston

Research output: Contribution to journalArticlepeer-review

130 Citations (Scopus)


Respiratory syncytial virus (RSV) infection causes bronchiolitis and pneumonia in infants. RSV has a linear single-stranded RNA genome encoding 11 proteins, 2 of which are nonstructural (NS1 and NS2). RSV specifically downregulates STAT2 protein expression, thus enabling the virus to evade the host type I interferon response. Degradation of STAT2 requires proteasomal activity and is dependent on the expression of RSV NS1 and NS2 (NS1/2). Here we investigate whether RSV NS proteins can assemble ubiquitin ligase (E3) enzymes to target STAT2 to the proteasome. We demonstrate that NS1 contains elongin C and cullin 2 binding consensus sequences and can interact with elongin C and cullin 2 in vitro; therefore, NS1 has the potential to act as an E3 ligase. By knocking down expression of specific endogenous E3 ligase components using small interfering RNA, NS1/2, or RSV-induced STAT2, degradation is prevented. These results indicate that E3 ligase activity is crucial for the ability of RSV to degrade STAT2. These data may provide the basis for therapeutic intervention against RSV and/or logically designed live attenuated RSV vaccines.
Original languageEnglish
Pages (from-to)3428-3436
Number of pages9
JournalJournal of Virology
Issue number7
Publication statusPublished - Apr 2007

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Respiratory syncytial virus NS1 protein degrades STAT2 by using the elongin-cullin E3 ligase'. Together they form a unique fingerprint.

Cite this